Sangamo Therapeutics Inc. (OTCQB: SGMO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SANGAMO THERAPEUTICS INC.

Sangamo Therapeutics Inc. (OTCQB: SGMO)
Listen to this Section


$0.17
-0.0430 ( -20.00% ) 6.9M

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Clinical Trial Pipeline Stages


Drug Name Stage
Giroctocogene fitelparvovec (SB-525 / PF-07055480)DetailsBlood disorder, Rare diseases, Hemophilia, Rare genetic disease Phase 3
TX-200DetailsKidney disease, Kidney transplantation Phase 1/2
ST-920 (isaralgagene civaparvovec)DetailsFabry disease, Rare genetic disease Phase 1/2
BIVV003 (SAR445136)DetailsSickle cell disease, Blood disorder Failed
ST-400DetailsBlood disorder, Beta thalessemia Failed
SB-913DetailsGenetic disorder, Rare diseases, Mucopolysaccharidoses, Rare genetic disease, Mucopolysaccharidosis type II Failed
ST-503DetailsIdiopathic small fiber neuropathy Phase 1/2

Market Data


Open $0.17
Previous Close $0.22
Volume 6.9M
Market Cap $71.26M
Day Range $0.14 - $0.22
52 Week Range $0.10 - $0.77
Shares Outstanding 414.29M
Change % -20.00%
Net Change ▼ -0.0430
Insider Ownership 0.00%
Exchange OTCQB
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -10,569,305.00

Date Type Amount Purchased Purchaser
2024-06-13 Sale -892.00 Duraibabu Prathyusha
2024-06-06 Sale -25000.00 Meyers James R
2024-06-06 Sale -25000.00 Horn Margaret A
2024-06-06 Sale -25000.00 Beers Courtney
2024-06-06 Sale -25000.00 Hillan Kenneth J.
2024-06-06 Sale -25000.00 Carey Robert
2024-06-06 Sale -25000.00 PARKER H STEWART
2024-06-06 Sale -25000.00 Smith Karen L.
2024-06-06 Sale -25000.00 Markels John
2024-05-29 Sale -1787.00 Dubois-Stringfellow Nathalie

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 12, 2025
10-q Quarterly Reports 69 Nov 06, 2025
8-k 8K-related 14 Nov 06, 2025
8-k 8K-related 12 Oct 29, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025

Latest News


× Before browsing our site, please accept our cookies policy